TechNavio today launched its report Global Enzyme Inhibitors Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and the APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Some of the vendors are outsourcing different parts of research work such as product characterization testing and toxicology testing to different contract research organizations. Similarly, some vendors are increasingly outsourcing part of their enzyme inhibitor drug manufacturing or the entire manufacturing process to various contract manufacturing organizations. Thus, the increase in outsourcing of drug manufacturing is one of the trends witnessed by the market.”
According to the report, the increasing prevalence of diseases increases the demand for various drugs used in their treatment. This in turn increases the demand for enzyme inhibitors, thereby driving the growth of the Global Enzyme Inhibitors market.
Further, the report discusses that the patent expiry of top-selling drugs is a challenge for the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players. For further information on this report, please visit http://goo.gl/NmrFX
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Enzyme Inhibitors Market 2011-2015
